Employer-based patient-centered medication therapy management program: Evidence and recommendations for future programs

Objective To evaluate a patient-centered employer-based medication therapy management (MTM) program. Design Randomized controlled study. Setting Health promotion program at the University of Michigan from June 2009 to December 2011. Participants Employees, retirees, and their dependents taking seven...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Pharmacists Association 2012, Vol.52 (6), p.768-776
Hauptverfasser: Shimp, Leslie A., PharmD, MS, Kucukarslan, Suzan N., PhD, Elder, Jodie, PharmD, BCPS, Remington, Tami, PharmD, Wells, Trisha, PharmD, Choe, Hae Mi, PharmD, CDE, Lewis, Nancy J.W., PharmD, MPH, Kirking, Duane M., PharmD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To evaluate a patient-centered employer-based medication therapy management (MTM) program. Design Randomized controlled study. Setting Health promotion program at the University of Michigan from June 2009 to December 2011. Participants Employees, retirees, and their dependents taking seven or more prescription medications. Intervention Focus on Medicines (FOM) was a two-visit, patient-centered service with a 4-month follow-up. A comprehensive medication review occurred during the first visit. Pharmacists provided recommendations and a medication action plan at the second visit. The MAP incorporated patient preferences for problem resolution. Main outcome measures Patient uptake, medication cost, medication adherence, patient satisfaction with treatment, patient reasons for participation, patient satisfaction with the FOM program, drug-related problems, pharmacist recommendations, implementation of recommendations. Results The FOM program attracted 128 individuals wanting information about their medications and an individualized drug regimen assessment to ensure that their therapy was safe and effective and that all medications were necessary. On average, 3.3 medication therapy problems were identified per patient; most were safety related. Overall, 63% of pharmacist recommendations were implemented. When a prescriber was contacted, 83% of pharmacist recommendations were implemented. A reduction in drug cost for patients and the employer was shown. Patients reported improved convenience in taking medications and rated the program favorably. Conclusion A personalized dialogue about medication use appears to meet a need among individuals taking large numbers of medications. Understanding why patients participate in MTM programs and what program features patients appreciate is useful in designing quality MTM programs.
ISSN:1544-3191
1544-3450
DOI:10.1331/JAPhA.2012.11186